Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study

Abstract

Journal Article Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study Get access Robert P. Whitehead, Robert P. Whitehead Search for other works by this author on: Oxford Academic PubMed Google Scholar Kenneth J. Kopecky, Kenneth J. Kopecky Search for other works by this author on: Oxford Academic PubMed Google Scholar Michael K. Samson, Michael K. Samson Search for other works by this author on: Oxford Academic PubMed Google Scholar John J. Constanzi, John J. Constanzi Search for other works by this author on: Oxford Academic PubMed Google Scholar Ronald B. Natale, Ronald B. Natale Search for other works by this author on: Oxford Academic PubMed Google Scholar Lynn G. Feun, Lynn G. Feun Search for other works by this author on: Oxford Academic PubMed Google Scholar Evan M. Hersh, Evan M. Hersh Search for other works by this author on: Oxford Academic PubMed Google Scholar John J. Rinehart John J. Rinehart Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 83, Issue 17, 4 September 1991, Pages 1250–1252, https://doi.org/10.1093/jnci/83.17.1250 Published: 04 September 1991 Article history Received: 14 January 1991 Revision received: 28 May 1991 Accepted: 03 June 1991 Published: 04 September 1991